Ranitidine Hydrochloride Tablets IP 300 mg Manufacturer

Ranitidine Hydrochloride Tablets IP 300 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Ranitidine Hydrochloride Tablets IP 300 mg Manufacturer product packaging

Ranitidine Hydrochloride Tablets IP 300 mg | Manufacturer

Product image for Ranitidine Hydrochloride Tablets IP 300 mg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameRanitidine Hydrochloride
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049033
PharmacopoeiaIP
Product TypeTablet
CategoryGastrointestinal drugs – Acid Suppression
SubcategoryAcid Suppression
Active IngredientRanitidine Hydrochloride
Strength300 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryGastrointestinal drugs – Acid Suppression

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Ranitidine Hydrochloride Tablets IP 300 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Symptomatic relief and healing of erosive gastroesophageal reflux disease (GERD). 2. Treatment of gastric ulcers, duodenal ulcers, and NSAID-associated mucosal injury.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Ranitidine Hydrochloride Tablets IP 300 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameRanitidine Hydrochloride
CompositionRanitidine Hydrochloride
Strength300 mg
CategoryGastrointestinal drugs – Acid Suppression
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Ranitidine Hydrochloride Tablets IP 300 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Ranitidine Hydrochloride Tablets IP 300 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Ranitidine Hydrochloride Tablets IP 300 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally 30 to 60 minutes before morning meals (or as prescribed for antacids, after meals and at bedtime). Swallow whole with water; do not crush or chew enteric-coated tablets.
Side EffectsCommon: Headache, diarrhea, constipation, abdominal discomfort, nausea. Uncommon: Flatulence, dry mouth, dizziness, transient transaminase elevation. Rare: Hypomagnesemia, Clostridioides difficile-associated diarrhea, subacute cutaneous lupus.
Warnings and PrecautionsMasking Malignancy: Symptomatic relief does not preclude presence of gastric malignancy; perform diagnostic workup if alarm symptoms exist. Long-Term Bone Density: Extended chronic use may slightly elevate risk of osteoporosis-related fractures; ensure adequate calcium and vitamin D intake.
Contraindications1. Known hypersensitivity to Ranitidine Hydrochloride or substituted benzimidazoles / antacids.
2. Severe electrolyte imbalances (for magnesium/aluminum antacids in renal failure).
3. Concurrent administration with rilpivirine-containing products.
Drug Interactions1. pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Iron Salts): Reduced absorption due to elevated gastric pH.
2. Clopidogrel: Potential attenuation of antiplatelet activation by certain proton pump inhibitors.
3. Digoxin & Methotrexate: Elevated serum concentrations requiring dosage monitoring.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Ranitidine Hydrochloride Tablets IP 300 mg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Ranitidine Hydrochloride Tablets IP 300 mg?The source specification is IP; confirm the required standard before contracting.
What quality tests are applicable for Ranitidine Hydrochloride Tablets IP 300 mg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Ranitidine Hydrochloride Tablets IP 300 mg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Ranitidine Hydrochloride Tablets IP 300 mg?Provide forecast volume, target market, strength and packaging requirements.

Product Tags

Ranitidine Hydrochloride Tablets IP 300 mg ManufacturerRanitidine Hydrochloride 300 mgContract ManufacturingOEM & Quality ControlHealthy Life Pharma Pvt. Ltd.

Product Hashtags

#Ranitidine#Manufacturer#PharmaB2B

Related Products

Latest Posts